My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 473

    1.

    Impaired insulin-stimulated phosphorylation of Akt and AS160 in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment.

    Højlund K, Glintborg D, Andersen NR, Birk JB, Treebak JT, Frøsig C, Beck-Nielsen H, Wojtaszewski JF.

    Diabetes. 2008 Feb;57(2):357-66. Epub 2007 Oct 31.PMID: 17977950 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Impaired insulin activation and dephosphorylation of glycogen synthase in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment.

    Glintborg D, Højlund K, Andersen NR, Hansen BF, Beck-Nielsen H, Wojtaszewski JF.

    J Clin Endocrinol Metab. 2008 Sep;93(9):3618-26. Epub 2008 Jun 10.PMID: 18544618 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Effect of pioglitazone on glucose metabolism and luteinizing hormone secretion in women with polycystic ovary syndrome.

    Glintborg D, Hermann AP, Andersen M, Hagen C, Beck-Nielsen H, Veldhuis JD, Henriksen JE.

    Fertil Steril. 2006 Aug;86(2):385-97. Epub 2006 Jun 16.PMID: 16782094 [PubMed - indexed for MEDLINE]Related articles

    4.

    Pioglitazone enhances mitochondrial biogenesis and ribosomal protein biosynthesis in skeletal muscle in polycystic ovary syndrome.

    Skov V, Glintborg D, Knudsen S, Tan Q, Jensen T, Kruse TA, Beck-Nielsen H, Højlund K.

    PLoS One. 2008 Jun 18;3(6):e2466.PMID: 18560589 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Polycystic ovary syndrome is associated with tissue-specific differences in insulin resistance.

    Ciaraldi TP, Aroda V, Mudaliar S, Chang RJ, Henry RR.

    J Clin Endocrinol Metab. 2009 Jan;94(1):157-63. Epub 2008 Oct 14.PMID: 18854391 [PubMed - indexed for MEDLINE]Related articles

    6.

    Soluble CD36 and risk markers of insulin resistance and atherosclerosis are elevated in polycystic ovary syndrome and significantly reduced during pioglitazone treatment.

    Glintborg D, Højlund K, Andersen M, Henriksen JE, Beck-Nielsen H, Handberg A.

    Diabetes Care. 2008 Feb;31(2):328-34. Epub 2007 Nov 13.PMID: 18000176 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Reduced expression of nuclear-encoded genes involved in mitochondrial oxidative metabolism in skeletal muscle of insulin-resistant women with polycystic ovary syndrome.

    Skov V, Glintborg D, Knudsen S, Jensen T, Kruse TA, Tan Q, Brusgaard K, Beck-Nielsen H, Højlund K.

    Diabetes. 2007 Sep;56(9):2349-55. Epub 2007 Jun 11.PMID: 17563058 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Effects of endurance exercise training on insulin signaling in human skeletal muscle: interactions at the level of phosphatidylinositol 3-kinase, Akt, and AS160.

    Frøsig C, Rose AJ, Treebak JT, Kiens B, Richter EA, Wojtaszewski JF.

    Diabetes. 2007 Aug;56(8):2093-102. Epub 2007 May 18.PMID: 17513702 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Insulin-stimulated phosphorylation of the Akt substrate AS160 is impaired in skeletal muscle of type 2 diabetic subjects.

    Karlsson HK, Zierath JR, Kane S, Krook A, Lienhard GE, Wallberg-Henriksson H.

    Diabetes. 2005 Jun;54(6):1692-7.PMID: 15919790 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Metabolic and hormonal changes induced by pioglitazone in polycystic ovary syndrome: a randomized, placebo-controlled clinical trial.

    Aroda VR, Ciaraldi TP, Burke P, Mudaliar S, Clopton P, Phillips S, Chang RJ, Henry RR.

    J Clin Endocrinol Metab. 2009 Feb;94(2):469-76. Epub 2008 Nov 4.PMID: 18984667 [PubMed - indexed for MEDLINE]Related articles

    11.

    Troglitazone therapy improves endothelial function to near normal levels in women with polycystic ovary syndrome.

    Paradisi G, Steinberg HO, Shepard MK, Hook G, Baron AD.

    J Clin Endocrinol Metab. 2003 Feb;88(2):576-80.PMID: 12574183 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Effects of metformin and rosiglitazone treatment on insulin signaling and glucose uptake in patients with newly diagnosed type 2 diabetes: a randomized controlled study.

    Karlsson HK, Hällsten K, Björnholm M, Tsuchida H, Chibalin AV, Virtanen KA, Heinonen OJ, Lönnqvist F, Nuutila P, Zierath JR.

    Diabetes. 2005 May;54(5):1459-67.PMID: 15855334 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Discovery of TBC1D1 as an insulin-, AICAR-, and contraction-stimulated signaling nexus in mouse skeletal muscle.

    Taylor EB, An D, Kramer HF, Yu H, Fujii NL, Roeckl KS, Bowles N, Hirshman MF, Xie J, Feener EP, Goodyear LJ.

    J Biol Chem. 2008 Apr 11;283(15):9787-96. Epub 2008 Feb 13.PMID: 18276596 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Skeletal muscle insulin signaling defects downstream of phosphatidylinositol 3-kinase at the level of Akt are associated with impaired nonoxidative glucose disposal in HIV lipodystrophy.

    Haugaard SB, Andersen O, Madsbad S, Frøsig C, Iversen J, Nielsen JO, Wojtaszewski JF.

    Diabetes. 2005 Dec;54(12):3474-83.PMID: 16306364 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Distinct signals regulate AS160 phosphorylation in response to insulin, AICAR, and contraction in mouse skeletal muscle.

    Kramer HF, Witczak CA, Fujii N, Jessen N, Taylor EB, Arnolds DE, Sakamoto K, Hirshman MF, Goodyear LJ.

    Diabetes. 2006 Jul;55(7):2067-76.PMID: 16804077 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Fatty acid-induced insulin resistance: decreased muscle PI3K activation but unchanged Akt phosphorylation.

    Kruszynska YT, Worrall DS, Ofrecio J, Frias JP, Macaraeg G, Olefsky JM.

    J Clin Endocrinol Metab. 2002 Jan;87(1):226-34.PMID: 11788651 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Reduction in hematocrit level after pioglitazone treatment is correlated with decreased plasma free testosterone level, not hemodilution, in women with polycystic ovary syndrome.

    Berria R, Gastaldelli A, Lucidi S, Belfort R, De Filippis E, Easton C, Brytzki R, Cusi K, Jovanovic L, DeFronzo R.

    Clin Pharmacol Ther. 2006 Aug;80(2):105-14. Epub 2006 Jun 30.PMID: 16890572 [PubMed - indexed for MEDLINE]Related articles

    18.

    Inhibition of contraction-stimulated AMP-activated protein kinase inhibits contraction-stimulated increases in PAS-TBC1D1 and glucose transport without altering PAS-AS160 in rat skeletal muscle.

    Funai K, Cartee GD.

    Diabetes. 2009 May;58(5):1096-104. Epub 2009 Feb 10.PMID: 19208911 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Role of Akt substrate of 160 kDa in insulin-stimulated and contraction-stimulated glucose transport.

    Cartee GD, Wojtaszewski JF.

    Appl Physiol Nutr Metab. 2007 Jun;32(3):557-66. Review.PMID: 17510697 [PubMed - indexed for MEDLINE]Related articles

    20.

    The effect of exercise and insulin on AS160 phosphorylation and 14-3-3 binding capacity in human skeletal muscle.

    Howlett KF, Mathews A, Garnham A, Sakamoto K.

    Am J Physiol Endocrinol Metab. 2008 Feb;294(2):E401-7. Epub 2007 Nov 27.PMID: 18042670 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity